Effect of Jawarish Zarooni and Sharbat Buzoori in a Diagnosed Case of Nephrotic Syndrome

Authors

  • Rabia Nizam
  • Mohammad Shakeel Ansari
  • Fazlur Rehman

Abstract

Nephrotic syndrome is a manifestation of kidney disease involving the glomeruli, characterized by oedema, proteinuria, hyperlipidemia and low serum albumin. It may be caused by primary kidney disease such as focal segmental glomerulosclerosis, and mutations in the podocin gene (shown in familial and sporadic forms of steroid-resistant nephrotic syndrome). A study by Michael B. Rothenberg and Walter Heymann M. showed 5-year survey of the incidence of the nephrotic syndrome in children in the state of Ohio, in which there were 0.5 new cases per year per 100,000 total populations and 2.3 new cases per year per 100,000 children aged 0 to 9 years with a total population of 8,000,000. Recent prospective studies revealed an incidence of 1.15 to 2.1/100,000 children/year. We presented a case of nephrotic syndrome treated with Unani formulation “Jawarish Zarooni” along with Sharbat Buzoori. Patient responded well and got complete relief with the formulation.

 

Keywords: Glomerulosclerosis, Jawarish Zarooni, nephrotic syndrome, podocin gene, Sharbat Buzoori

 

Cite this Article

Rabia Nizam, Mohammad Shakeel Ansari, Fazlur Rehman. Effect of Jawarish Zarooni and Sharbat Buzoori in a Diagnosed Case of Nephrotic Syndrome. Research & Reviews: Journal of Surgery. 2020; 9(1): 33–35p.

Downloads

Published

2020-05-16

Issue

Vol. 9 No. 1 (2020)

Section

Case Study

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have neither given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.